MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$187,546
Net Income
-$2,980,548
Net Profit Margin
-1589.24%
EPS
-$0.2
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
187,546
152,455
-
-
Cost of revenues
319,889
242,325
-
-
Selling, general and administrative
2,593,671
2,248,566
-
-
Loss from operations
-
-
-1,713,729.5*
-3,672,148
Sale of royalty and milestone rights, net
-
-
0*
0
Research and development
241,966
660,462
-
-
Interest expense
-
-
100,153*
213,171
Total operating expenses
2,835,637
2,909,028
-
-
Interest income
-
-
96,247.5*
319,147
Loss from operations
-2,967,980
-
-
-
Other income (expense), net
-
-
275,917*
3,406
Loss from operations
-2,967,980
-2,998,898
-
-
Net loss
-2,982,773
-2,999,889
-1,441,718
-3,562,766
Net loss to common stockholders
-
-
-1,431,743*
-
Foreign currency translation adjustments
2,225
44,542
-22,739*
6,860
Comprehensive loss
-2,980,548
-2,955,347
-1,454,482
-3,555,906
Basic EPS
-0.2
-0.21
-0.102
-0.28
Diluted EPS
-0.2
-0.21
-0.102
-0.28
Basic Average Shares
14,889,832
14,522,835
14,329,688
12,755,112
Diluted Average Shares
14,889,832
14,522,835
14,329,688
12,755,112
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$2,980,548
Foreign currency
translation adjustments
$2,225
Net loss
-$2,982,773
(25.74%↑ Y/Y)
Loss from operations
-$2,967,980
(22.46%↑ Y/Y)
Loss from operations
-$2,967,980
(22.46%↑ Y/Y)
Total revenue
$187,546
Total operating
expenses
$2,835,637
Cost of revenues
$319,889
Selling, general and
administrative
$2,593,671
Research and development
$241,966
Buy us a coffee
Dare Bioscience, Inc. (DARE)
Dare Bioscience, Inc. (DARE)